Study how chemotherapy affects brain function in breast cancer
Part of Cancer clinical trials.
This study looks at changes in thinking and brain function in people with early to locally advanced breast cancer before and during chemotherapy. You may also be offered a brain MRI in a separate optional part of the research to learn more about brain changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman, age 21 or older, and can read and speak English
- If you have breast cancer: it is invasive and not metastatic (stage I–IIIC), and you will start chemotherapy with Adriamycin and Cytoxan for the first time
- You have not received chemotherapy before (chemotherapy-naïve)
- You have not been hospitalized in the past year for a psychiatric illness
- You do not have diseases that affect the brain over time (like Alzheimer’s or Parkinson’s) and you do not have other brain nervous system conditions (like multiple sclerosis or major movement disorders)
- You must not be scheduled to get radiation at the same time as chemotherapy, and you must not be colorblind
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a structured exercise program can help protect or improve thinking and memory in people with breast cancer while they are starting chemotherapy after surgery. It may help with “chemo brain” by targeting brain function during treatment.
This study looks at how chemotherapy may affect memory and thinking, using thinking tests and possibly brain imaging. It compares older breast cancer patients who do and do not get chemotherapy, plus a group of healthy older adults.
This study checks how breast cancer affects memory and thinking before other treatments start. It may help doctors better understand cognitive changes and who is most at risk.
This study looks at how chemotherapy may affect thinking and memory in people with HER2-negative breast cancer. It uses brain scans during or after chemotherapy to understand these changes and potentially guide support in the future.
This study looks at memory and thinking problems in women who have finished treatment for hormone-positive breast cancer. The goal is to find ways to help with these issues.
This study looks at cognitive (thinking and memory) changes in people with colorectal cancer who start certain chemotherapy drugs. It aims to understand how treatment affects the brain and may guide better monitoring or support during care.
Hear when a new Cancer Related Cognitive Difficulties trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.